20671-4 |
Amino acids |
Imp |
Ser/Plas |
Pt |
Nom |
|
|
DEPRECATED |
Deprecated Amino acids [interpretation] in Serum or Plasma |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
20671-4 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Amino acids SerPl-Imp |
|
|
|
|
|
AA; Acd; Acid; Amino acid; Amino acids.total; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
20672-2 |
Actinobacillus pleuropneumoniae serotype |
Prid |
Isolate |
Pt |
Nom |
|
|
ACTIVE |
Actinobacillus pleuropneumoniae serotype [Identifier] in Isolate |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20672-2 |
|
|
|
|
Both |
|
|
|
0 |
A pleuropn Sertyp Islt |
|
|
|
|
|
A pleuropn; A pleuropn Sertyp; A pleuropneumoniae; Actino; Contagious swine pleuropneumonia; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Sertyp |
2.19 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
20673-0 |
Actinobacillus pleuropneumoniae Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Actinobacillus pleuropneumoniae Ab [Presence] in Serum |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20673-0 |
|
|
|
|
Both |
|
|
|
0 |
A pleuropn Ab Ser Ql |
|
|
|
|
|
A pleuropn; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20674-8 |
Avian adenovirus 2 Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune diffusion |
|
ACTIVE |
Avian adenovirus 2 Ag [Presence] in Tissue by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20674-8 |
|
Immune diffusion |
|
|
Both |
|
|
|
0 |
FAdV2 Ag Tiss Ql ID |
|
|
|
|
|
Adeno virus; Antigen; Antigens; Bird; Celo; FAdV; FAdV2; Fowl; HAdV; ID; II; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20675-5 |
Bovine adenovirus 3 Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Bovine adenovirus 3 Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20675-5 |
|
IF |
|
|
Both |
|
|
|
0 |
BAdV3 Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Adeno virus; AdV B(3); Anticomplement Immunofluorescence; Antigen; Antigens; BAdV; BAdV3; Beef; DFA; FA; Fluorescent antibody; Fluoresent; HAdV; ID; IFA; III; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20676-3 |
Bovine adenovirus 5 Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Bovine adenovirus 5 Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20676-3 |
|
IF |
|
|
Both |
|
|
|
0 |
BAdV5 Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Adeno virus; Anticomplement Immunofluorescence; Antigen; Antigens; BAdV; BAdV5; Beef; DFA; FA; Fluorescent antibody; Fluoresent; HAdV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20677-1 |
Equine adenovirus Ag |
PrThr |
Lung |
Pt |
Ord |
IF |
|
ACTIVE |
Equine adenovirus Ag [Presence] in Lung by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20677-1 |
|
IF |
|
|
Both |
|
|
|
0 |
EAdV Ag Lung Ql IF |
|
|
|
|
|
ACIF; Adeno virus; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; EAdV; Equin; FA; Fluorescent antibody; Fluoresent; HAdV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF; Vet; Veterinary |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20678-9 |
Alkaloid |
Prid |
Urine |
Pt |
Nom |
TLC |
|
ACTIVE |
Alkaloid identified in Urine by Thin layer chromatography (TLC) |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20678-9 |
|
TLC |
|
|
Both |
|
|
|
0 |
Alkaloid Ur TLC |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; Thin Layer Chromatography; UA; UR; Urn |
2.79 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
20679-7 |
Alkaloid |
Prid |
Plant |
Pt |
Nom |
TLC |
|
ACTIVE |
Alkaloid identified in Plant by Thin layer chromatography (TLC) |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20679-7 |
|
TLC |
|
|
Both |
|
|
|
0 |
Alkaloid Plant TLC |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; Thin Layer Chromatography |
2.79 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
2068-5 |
Chloride |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
2068-5 |
|
|
|
|
Both |
|
|
|
0 |
Chloride Amn-sCnc |
|
|
|
Y |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Cl; Cl-; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.34 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
20680-5 |
Alkaloid |
Prid |
Ingesta |
Pt |
Nom |
TLC |
|
ACTIVE |
Alkaloid identified in Ingesta by Thin layer chromatography (TLC) |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20680-5 |
|
TLC |
|
|
Both |
|
|
|
0 |
Alkaloid Ingesta TLC |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; Thin Layer Chromatography |
2.79 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
20681-3 |
Alpha tocopherol |
MCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Alpha tocopherol [Mass/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
mg/g |
|
|
|
|
|
|
CHEM |
|
20681-3 |
|
|
|
|
Both |
|
|
|
0 |
A-Tocopherol Vit E Tiss-mCnt |
|
|
|
Y |
|
Alfa; A-Tocopherol Vit E; Chemistry; Mass Content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Tocopherols; Vit E; Vitamin E |
2.73 |
1.0m |
|
|
|
|
|
|
|
mg/g |
|
|
|
0 |
20682-1 |
Ammonia |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Ammonia [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/dL |
|
|
|
|
|
|
CHEM |
|
20682-1 |
|
|
|
|
Both |
|
|
|
0 |
Ammonia Ur-mCnc |
|
|
|
Y |
|
Amm; Ammon; Amon; Chemistry; Kidney; Level; Mass concentration; Nephrology; NH3; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
20683-9 |
Ammonia |
MCnc |
Ingesta |
Pt |
Qn |
|
|
ACTIVE |
Ammonia [Mass/volume] in Ingesta |
|
MIN |
DefinitionDescription |
|
|
ug/dL |
|
|
|
|
|
|
CHEM |
|
20683-9 |
|
|
|
|
Both |
|
|
|
0 |
Ammonia Ingesta-mCnc |
|
|
|
Y |
|
Amm; Ammon; Amon; Chemistry; Hepatology; Kidney; Level; Liver; Mass Concentration; Nephrology; NH3; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal |
2.42 |
1.0m |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
20684-7 |
Ammonia |
MCnc |
Ser |
Pt |
Qn |
|
|
DISCOURAGED |
Ammonia [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/dL |
|
|
|
|
|
|
CHEM |
|
20684-7 |
|
|
|
|
Both |
|
|
|
0 |
Ammonia Ser-mCnc |
|
|
|
Y |
|
Amm; Ammon; Amon; Chemistry; Hepatology; Kidney; Level; Liver; Mass Concentration; Nephrology; NH3; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Serum; SR |
2.4 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
20685-4 |
Anaplasma marginale Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl.card |
|
ACTIVE |
Anaplasma marginale Ab [Presence] in Serum by Card agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20685-4 |
|
Aggl.card |
|
|
Both |
|
|
|
0 |
A marginale Ab Ser Ql Card aggl |
|
|
|
|
|
A marginale; ABS; Aby; Agg; Agglut; Agglutination; Anaplasmosis; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bovine anaplasmosis; Card aggl; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20686-2 |
Anaplasma marginale Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Anaplasma marginale Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20686-2 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
A marginale Ab Ser Ql CF |
|
|
|
|
|
A marginale; ABS; Aby; Anaplasmosis; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bovine anaplasmosis; CF; Comp fixation; Compfix; Complement fixation; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20687-0 |
Arsenic |
MCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Arsenic [Mass/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
20687-0 |
|
|
|
|
Both |
|
|
|
0 |
Arsenic Gast-mCnc |
|
|
|
Y |
|
AS; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
20688-8 |
Aspergillus sp |
Prid |
Litter |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Aspergillus sp identified in Litter by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20688-8 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Aspergillus Litter Cult |
|
|
|
|
|
Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; C&S; Cult; Cultures; Farmers lung; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Spec; species; spp |
2.79 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
20689-6 |
Babesia caballi Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Babesia caballi Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20689-6 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
B caballi Ab Ser Ql CF |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B caballi; Babesia cabellii; Babesiosis; CF; Comp fixation; Compfix; Complement fixation; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Piroplasmosis; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
2069-3 |
Chloride |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
2069-3 |
|
|
|
|
Both |
|
|
|
0 |
Chloride Bld-sCnc |
|
|
|
Y |
|
Blood; Chemistry; Cl; Cl-; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UniversalLabOrders; WB; Whole blood |
2.73 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
20690-4 |
Theileria equi Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Theileria equi Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20690-4 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
T equi Ab Ser Ql CF |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Babesia equi; Babesiosis; CF; Comp fixation; Compfix; Complement fixation; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Piroplasmosis; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; T equi; Theileriosis; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20691-2 |
Bacillus anthracis |
ACnc |
XXX |
Pt |
Ord |
Organism specific culture |
|
DEPRECATED |
Deprecated Bacillus anthracis [Presence] in Unspecified specimen by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20691-2 |
|
Organism specific culture |
|
|
|
|
|
|
0 |
Deprecated B anthracis XXX Ql Cult |
|
|
|
|
|
Anthrax; Arbitrary concentration; B anthracis; C&S; Charbon; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Malignant carbuncle; Malignant pustule; Microbiology; Milzbrand; Misc; Miscellaneous; Ordinal; Other; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; Splenic fever; To be specified in another part of the message; Unspecified; Woolsorters disease |
2.69 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
20692-0 |
Bacillus cereus |
PrThr |
Food |
Pt |
Ord |
Culture.FDA method |
|
ACTIVE |
Bacillus cereus [Presence] in Food by Culture FDA method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20692-0 |
|
Culture.FDA method |
|
|
Both |
|
|
|
0 |
B cereus Food Ql Cult FDA |
|
|
|
|
|
B cereus; C&S; Cult; Cult FDA; Cultures; Food sample; Foods; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20693-8 |
Bacteria |
Prid |
Litter |
Pt |
Nom |
Aerobic culture |
|
ACTIVE |
Bacteria identified in Litter by Aerobe culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20693-8 |
|
Aerobic culture |
|
|
Both |
|
|
|
0 |
Bacteria Litter Aerobe Cult |
|
|
|
|
|
Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random |
2.78 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |